Nectar Lifesci.

17
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE023H01027
  • NSEID: NECLIFE
  • BSEID: 532649
INR
11.03
0.02 (0.18%)
BSENSE

Sep 21, 03:30 PM

BSE+NSE Vol: 1.03 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Nectar Lifesci. Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
-788.00
-161.00
18.00
-42.00
34.00
-59.00
Adjustment
234.00
139.00
137.00
98.00
125.00
125.00
Changes In working Capital
205.00
191.00
68.00
77.00
-64.00
-40.00
Cash Flow after changes in Working Capital
-348.00
169.00
224.00
133.00
95.00
25.00
Cash Flow from Operating Activities
-348.00
169.00
224.00
133.00
95.00
21.00
Cash Flow from Investing Activities
1,208.00
-41.00
-17.00
51.00
16.00
-28.00
Cash Flow from Financing Activities
-766.00
-128.00
-205.00
-185.00
-119.00
11.00
Net Cash Inflow / Outflow
92.00
0.00
2.00
0.00
-7.00
4.00
Opening Cash & Cash Equivalents
19.00
19.00
17.00
17.00
25.00
21.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
112.00
19.00
19.00
17.00
17.00
25.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Nectar Lifesci.
Markets Mojo
Figures in Cr
standaloned Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
-788.9
6.21
-794.00
-12803.70%
Adjustment
234.23
0.79
234.00
29549.37%
Changes In working Capital
137.31
-14.79
151.00
1028.40%
Cash Flow after changes in Working Capital
-417.35
-7.78
-410.00
-5264.40%
Cash Flow from Operating Activities
-417.35
-9.42
-408.00
-4330.47%
Cash Flow from Investing Activities
1205.41
-14.5
1,219.00
8413.17%
Cash Flow from Financing Activities
-699.15
25.19
-724.00
-2875.51%
Net Cash Inflow / Outflow
88.91
1.26
87.00
6956.35%
Opening Cash & Cash Equivalents
19.22
0.02
19.00
96000.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
108.13
1.28
107.00
8347.66%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is -305.81% vs -24.59% in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
-348.72
169.44
-305.81%